Home tonometry device correlates with GAT

A rebound tonometer designed for patients to use at home can obtain IOP measurements comparable to Goldmann applanation tonometry (GAT).[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/home-tonometry-device-correlates-with-gat/

IOP self-monitoring device clears FDA

The FDA has approved Icare HOME, a rebound tonometer designed for patients to use at home, offering the ability to track IOP fluctuations throughout the day.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/iop-self-monitoring-device-clears-fda/

FDA fast tracks ocular melanoma treatment

A new class of therapy that can selectively destroy cancer cells using a light-activated viral nanoparticle has received FDA fast track designation for the treatment of ocular melanoma.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/fda-fast-tracks-ocular-melanoma-treatment/

Non-mydriatic DR screening effective in reaching minority populations

Telemedicine in an urban setting shows significant potential for intervention in the earliest phases of diabetic retinopathy when treatment can prevent vision loss.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/non-mydriatic-dr-screening-effective-in-reaching-minority-populations/

Functional retinal prosthesis created from organic materials

An organic retinal prosthesis has restored light perception in blind rats with retinitis pigmentosa, suggesting that restoring sight in humans may soon be possible without the complex hardware required for today s devices.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/functional-retinal-prosthesis-created-from-organic-materials/

Scientists zero in on PCO cause

Scientists have found that the growth factor TGF-beta may play a role in the formation of posterior capsule opacification (PCO), suggesting a new direction for research.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/scientists-zero-in-on-pco-cause/

Sjögren’s dry eye treatment proceeds to human trials

A new dry eye drug that aims to stimulate tear production will advance to phase 1/2 clinical testing this month.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/sjogrens-dry-eye-treatment-proceeds-to-human-trials/